ORYZON to participate in upcoming events in January

Oryzon Genomics S.A., (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events:

9th Sachs Annual Neuroscience Innovation Forum, January 11

Location: Marines’ Memorial Club, San Francisco, USA

Presentation type: Company presentation

Presentation time: 10:35 am (PST)

44th Annual J.P. Morgan Healthcare Conference, January 12-15

Location: San Francisco, USA

Allinvest Securities Biomed Forum, January 29 

Location: Le Salons Hoche, Paris, France

Oryzon management will be available for one-on-one meetings during the conferences.